Evidence map›Paper›PMID 40190671›Full record

ArticleAdvanced pharmaceutical bulletin2024

Developing and Applying a Single Strategy for Improved Intestinal Permeability of Diverse and Complex Phytomolecules: Nanoformulations of Rutin, Quercetin, Thymoquinone Provide Proof-of-Concept.

Rajani Mathur, Sahiba Khan, Ruchi Tripathi, Saima Amin, Saumitra Dey Choudhary

Abstract read
In one paragraph

Article in Advanced pharmaceutical bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rajani MathurDepartment of Pharmacology, Delhi Institute of Pharmaceutical Sciences & Research, DPSRU, New Delhi, India.ORCID https://orcid.org/0000-0001-8566-652X
Sahiba KhanDepartment of Pharmacology, Delhi Institute of Pharmaceutical Sciences & Research, DPSRU, New Delhi, India.
Ruchi TripathiDepartment of Pharmacology, Delhi Institute of Pharmaceutical Sciences & Research, DPSRU, New Delhi, India.ORCID https://orcid.org/0000-0002-5963-4679
Saima AminPharmaceutics School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India.ORCID https://orcid.org/0000-0003-2026-4866
Saumitra Dey ChoudharyAll India Institute of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The clinical use and efficacy of phytomolecules are often hampered as their complex structure, poor aqueous solubility and low biological stability restricts their intestinal permeability which results in low oral bioavailability. Rutin (RT), quercetin (QU), thymoquinone (TQ) are few of such potent and therapeutically versatile phytomolecules that await maximal utilization. To address this lacuna, an attempt was made to develop a single strategy for enhanced intestinal permeation that can be applied to diverse phytomolecules. Methods: A simple idea with easy-to-apply method was developed that involved preparing nanoparticles of the phytomolecules RT, QU, TQ using Eudragit matrix (RT-PNP, QU-PNP, TQ-PNP) and examined for particle characteristics, EE, in vitro release and kinetics. Phytomolecule loaded nanoparticle (PNPs) were encapsulated in HPMC grade capsule shell and evaluated for intestinal permeability by everted gut sac method. Results: The average particle sizes of RT-PNP, QU-PNP, TQ-PNP were 446±0.152, 39.6±0.006 and 186±0.513 nm, polydispersity indices were<0.5 with negative zeta potential. The % release of respective phytomolecule from RT-PNP, QU-PNP, TQ-PNP was significantly higher ( Conclusion: Developed PNPs appear to be a good approach to increase the permeability of hydrophobic phytomolecules.

Indexed as

Apparent permeabilityEudragitNanoparticleQuercetinRutinThymoquinone

Identifiers

PMID40190671
PMCPMC11970504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.